Cite
HARVARD Citation
Law, J. et al. (2020). Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy. Journal of the American Heart Association. 9 (7), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Law, J. et al. (2020). Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy. Journal of the American Heart Association. 9 (7), p. n/a. [Online].